Navigation Links
Global Med Technologies(R), Inc. Licenses EdgeLab to Seven Laboratories at University Hospital of Reims, France
Date:10/15/2009

DENVER, Oct. 15 /PRNewswire-FirstCall/ -- Global Med Technologies®, Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today announced that its Inlog subsidiary has licensed its EdgeLab Laboratory Information Management Software (marketed as "Labo Serveur" in France) to the seven laboratories at University Hospital of Reims. Financial terms of this substantial agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

The Reims' laboratories handle a full range of clinical laboratory functions with their daily workload exceeding 700 patient files per day. EdgeLab will be deployed on over 170 workstations and will be directly connected to over 40 laboratory analyzers.

According to Mrs. Cornu, the IT representative for the University Hospital of Reims, the reasons behind the hospital's choice were based on different factors: a technical architecture that corresponded to their desires, a more intuitive and user-friendly product than what the competition offered and a very broad functional basis that covered all of the requirements of the relevant wards. In addition, the on-site demonstrations and especially the visit to the University Hospital of Besancon were also very persuasive.

Since EdgeLab was introduced into the hospital market in 1999 as "Labo Serveur", it has become a leading laboratory information management system in Europe with more than 150 licensed laboratories. EdgeLab is connected to more than 1,000 analyzers and interchanges data with all major hospital healthcare software applications. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality. EdgeLab can be easily configured to meet the business needs of large, diverse, multi-site hospital laboratories, as well as small, single-site hospitals.

Will Willman, Global Med's Senior Vice President of Sales and Marketing EU/ME/Asia, commented, "We are very proud to have been selected by the University Hospital of Reims to assist their seven laboratories with our laboratory information management system. EdgeLab has proven capabilities for the complex requirements of multi-site university hospitals with multiple laboratories. We are looking forward to supporting University Hospital of Reims with quality products and services as they continue to provide excellent, advanced healthcare to patients in the greater Reims area."

About the University Hospital of Reims

The University Hospital of Reims, France, has almost 2,500 beds throughout its nine facilities. It handles 20,000 surgical procedures and 1,700 births each year at its pediatric facility. Its emergency service manages 67,000 cases per year.

About Global Med Technologies®, Inc.

Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.

Global Med's domestic companies are Wyndgate Technologies®, a leader in software products and services for donor centers and hospital transfusion services; eDonor®, which offers web-based donor relationship management systems; and PeopleMed(TM), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.

For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

SOURCE Global Med Technologies, Inc.


'/>"/>
SOURCE Global Med Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):